IN2014MN02269A - - Google Patents

Info

Publication number
IN2014MN02269A
IN2014MN02269A IN2269MUN2014A IN2014MN02269A IN 2014MN02269 A IN2014MN02269 A IN 2014MN02269A IN 2269MUN2014 A IN2269MUN2014 A IN 2269MUN2014A IN 2014MN02269 A IN2014MN02269 A IN 2014MN02269A
Authority
IN
India
Prior art keywords
relates
extract
composition
plant
treatment
Prior art date
Application number
Inventor
Arvind Saklani
Nilesh Malpure
Parikshit Gaikwad
Satish Namdeo Sawant
Tukaram Kisanrao Mane
Somesh Sharma
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of IN2014MN02269A publication Critical patent/IN2014MN02269A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Abstract

The present invention relates to a herbal composition comprising a therapeutically effective amount of an extract of the plant as an active ingredient and optionally a pharmaceutically acceptable carrier. The invention also relates to a process for the preparation of the extract. The invention also relates to a method for the treatment of metabolic disorders using the said composition. The present invention also relates to a composition comprising a therapeutically effective amount of an extract of the plant for use in combination with one or more further therapeutically active agent for the treatment of metabolic disorders.
IN2269MUN2014 2012-04-23 2013-04-22 IN2014MN02269A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261636792P 2012-04-23 2012-04-23
PCT/IB2013/053155 WO2013160811A1 (en) 2012-04-23 2013-04-22 Composition for treating metabolic disorders

Publications (1)

Publication Number Publication Date
IN2014MN02269A true IN2014MN02269A (en) 2015-07-24

Family

ID=49482298

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2269MUN2014 IN2014MN02269A (en) 2012-04-23 2013-04-22

Country Status (16)

Country Link
US (1) US20150290265A1 (en)
EP (1) EP2841080A4 (en)
JP (1) JP2015514797A (en)
KR (1) KR20150003862A (en)
CN (1) CN104244962A (en)
AU (1) AU2013254329A1 (en)
BR (1) BR112014026326A2 (en)
CA (1) CA2870907A1 (en)
IL (1) IL235317A0 (en)
IN (1) IN2014MN02269A (en)
MX (1) MX2014012742A (en)
NZ (1) NZ701133A (en)
RU (1) RU2014145931A (en)
SA (1) SA113340494B1 (en)
TW (1) TW201343174A (en)
WO (1) WO2013160811A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170368018A1 (en) * 2014-12-19 2017-12-28 Halo Life Science, Llc Use of ellagic acid dihydrate in pharmaceutical formulations to regulate blood glucose levels
IL304017A (en) 2017-01-06 2023-08-01 Yumanity Therapeutics Inc Methods for the treatment of neurological disorders
CA3083000A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. Compounds and uses thereof
RU2022101021A (en) 2018-01-10 2022-03-18 Брайтсид, Инк. METABOLISM MODULATION METHOD
AU2020383340A1 (en) 2019-11-11 2022-06-09 Brightseed, Inc Extract, consumable product and method for enriching bioactive metabolite in an extract
KR102408566B1 (en) * 2020-04-09 2022-06-16 대한민국 Composition for Improving Skin Wrinkles Using an Extract of Terminalia bialata

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005053864A (en) * 2003-08-06 2005-03-03 Ryukyu Bio Resource Kaihatsu:Kk Prophylactic and therapeutic agent for diabetes mellitus disease
JP2006188486A (en) * 2004-12-07 2006-07-20 Toyo Shinyaku:Kk Body fat accumulation-inhibiting or reducing agent
EP1906982A2 (en) * 2005-02-23 2008-04-09 Avesta Gengraine Technologies Pvt. Ltd Plant extracts and methods and uses therefore

Also Published As

Publication number Publication date
US20150290265A1 (en) 2015-10-15
EP2841080A4 (en) 2015-11-25
WO2013160811A1 (en) 2013-10-31
IL235317A0 (en) 2014-12-31
CN104244962A (en) 2014-12-24
MX2014012742A (en) 2015-04-08
RU2014145931A (en) 2016-06-20
TW201343174A (en) 2013-11-01
JP2015514797A (en) 2015-05-21
EP2841080A1 (en) 2015-03-04
AU2013254329A1 (en) 2014-11-13
BR112014026326A2 (en) 2017-06-27
KR20150003862A (en) 2015-01-09
CA2870907A1 (en) 2013-10-31
SA113340494B1 (en) 2015-12-24
NZ701133A (en) 2016-08-26

Similar Documents

Publication Publication Date Title
NZ700881A (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
NZ702663A (en) Nuclear transport modulators and uses thereof
MX360598B (en) Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof.
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
WO2014152029A3 (en) Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
MX365939B (en) Nuclear transport modulators and uses thereof.
IN2014MN02269A (en)
WO2015056094A3 (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent
WO2013114394A3 (en) A polyherbal composition for skin care
MX2019008817A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof.
EP2575842A4 (en) A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
WO2013175504A3 (en) Herbal composition for vaginal treatment
MX2020001428A (en) Compositions of grapiprant and methods for using the same.
GB2498677A (en) Extracts of cynanchum SP.and active ingredients contained therein in use of arthritis treatment
IN2014MN01933A (en)
BR112014004737A2 (en) Ambroxol Hydrochloride Compound Compound and Method of Preparation of Compound
MX2014014814A (en) Pharmaceutical composition for treating inflammation and pain.
MX357704B (en) O/w-emulsion-type topical pharmaceutical compositions containing a retinoid.
WO2013038200A3 (en) Neurodevelopmental disorders
WO2012108747A3 (en) Composition and cosmetic composition for treating brain cancer comprising helena root extract
IN2013MU03428A (en)
NZ629475A (en) Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
UA48784U (en) Composition for treating sexual disorders in women
MX357329B (en) Raw extract of a sechium edule hybrid, method for extracting same and use thereof for formulations having an antineoplastic effect.
IN2013MU02059A (en)